5-(chloromethyl)-3-(2-methoxyethyl)-1,2,4-oxadiazole, 95.0%, 1g

(2S,5S)-tert-butyl 5-(3-bromo-5-((diethoxyphosphoryl)methyl)benzyl)-2-(tert-butyl)-3-methyl-4-oxoimidazolidine-1-carboxylate, 98%, 50mg

(R)-(+)-3-Butyn-2-ol>98.0%(GC)5g

Thalidomide-O-amido-C4-NH2 (TFA), 500mg

2-Bromo-4-fluoro-1-isopropylbenzene, 97%, 250mg

4H-PYRROLO[2,3-D]THIAZOLE-5-CARBOXYLIC ACID, 97.0%, 500mg

1-Methyl-6,7-dihydro-1H-indol-4(5H)-one, 95.0%, 500mg

1,4-BIS(4-CHLOROBENZOYL)-PIPERAZINE, 95.0%, 10g

Standballon, HDPE, mit Hahnanschluss und Zapfhahn, 60 l, 1 Stück

(E)-1-(Pyridin-2-yl)ethanone O-benzyl oxime, 97%, 250mg

N-iso-Propyl 4-bromo-2-nitroaniline, 98.0%, 1g

PAR [=4-(2-Pyridylazo)resorcinol] [Spectrophotometric reagent for transition metals]>98.0%(HPLC)(T)5g

((3aR,4R,6R,6aR)-6-(6-Amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl ((R)-2-((tert-butoxycarbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)sulfamate, 95%, 25mg